REVIEW 1 cited by
Ambient AI Scribing Support: Comparing the Performance of Specialized AI Agentic Architecture to Leading Foundational Models
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
This study compares Sporo Health's AI Scribe, a proprietary model fine-tuned for medical scribing, with various LLMs (GPT-4o, GPT-3.5, Gemma-9B, and Llama-3.2-3B) in clinical documentation. We analyzed de-identified patient transcripts from partner clinics, using clinician-provided SOAP notes as the ground truth. Each model generated SOAP summaries using zero-shot prompting, with performance assessed via recall, precision, and F1 scores. Sporo outperformed all models, achieving the highest recall (73.3%), precision (78.6%), and F1 score (75.3%) with the lowest performance variance. Statistically significant differences (p < 0.05) were found between Sporo and the other models, with post-hoc tests showing significant improvements over GPT-3.5, Gemma-9B, and Llama 3.2-3B. While Sporo outperformed GPT-4o by up to 10%, the difference was not statistically significant (p = 0.25). Clinical user satisfaction, measured with a modified PDQI-9 inventory, favored Sporo. Evaluations indicated Sporo's outputs were more accurate and relevant. This highlights the potential of Sporo's multi-agentic architecture to improve clinical workflows.
Forward citations
Cited by 1 Pith paper
-
Toward the Autonomous AI Doctor: Quantitative Benchmarking of an Autonomous Agentic AI Versus Board-Certified Clinicians in a Real World Setting
In a retrospective sample of 500 urgent-care telehealth visits, a proprietary AI doctor matched clinicians' top diagnosis 81% of the time and treatment plans 99.2% of the time, but the design cannot support claims of ...
Discussion (0). Sign in to comment.